Lloyd Park’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Lloyd Park’s Portfolio XBI Stock Details XBI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	$1.45M	Sell	18,297 -11,011	-38%	-$928K	1.79%	12
2022 Q2	$2.18M	Buy	29,308 +11,200	+62%	+$841K	2.28%	7
2022 Q1	$1.63M	Hold	18,108	–	–	1.8%	15
2021 Q4	$2.03M	Buy	+18,108	New	+$2.18M	1.13%	11

Other funds holding XBI

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

Toronto Dominion Bank Toronto, Ontario, Ontario, Canada $86.4B AUM 59.51% 1-Year Est. Return

Clal Insurance Tel-Aviv, Israel $22.3B AUM 79.91% 1-Year Est. Return

APM

Avidity Partners Management Dallas, Texas $624M AUM 250.2% 1-Year Est. Return

Lloyd Park's XBI Position: Q3 2022 in Review

Lloyd Park reduced its State Street SPDR S&P Biotech ETF (XBI) stake by 38% in Q3 2022, selling an estimated $928K and leaving 18,297 shares worth $1.45M. The position accounts for 1.79% of the portfolio, ranked #12.

Lloyd Park first reported a position in XBI in Q4 2021 and has held it in 4 quarters since. The position peaked at $2.18M in Q2 2022. 703 funds tracked by Wall St. Rank hold XBI as of Q3 2022.

Lloyd Park held 18,297 shares of State Street SPDR S&P Biotech ETF worth $1.45M as of Q3 2022.
Lloyd Park sold 11,011 State Street SPDR S&P Biotech ETF shares in Q3 2022, an estimated $928K.
State Street SPDR S&P Biotech ETF made up 1.79% of Lloyd Park's portfolio in Q3 2022, its #12 holding.
Lloyd Park first reported a position in State Street SPDR S&P Biotech ETF in Q4 2021 and has held it in 4 quarters since.
Lloyd Park's State Street SPDR S&P Biotech ETF position peaked at $2.18M in Q2 2022.
703 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q3 2022.

Based on Lloyd Park's 13F filing for Q3 2022, filed 14 Nov 2022.